Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation (Q39271419)

10 September 2017

title

Expression of R132H mutational IDH1 in human U87 glioblastoma cells affects the SREBP1a pathway and induces cellular proliferation (English)

1 reference

10 September 2017

1 reference

Jian Zhu

1

1 reference

10 September 2017

Gang Cui

2

1 reference

10 September 2017

Ming Chen

3

1 reference

10 September 2017

Qinian Xu

4

1 reference

10 September 2017

Xiuyun Wang

5

1 reference

10 September 2017

Dai Zhou

6

1 reference

10 September 2017

Shengxiang Lv

7

1 reference

10 September 2017

Linshan Fu

8

1 reference

10 September 2017

Zhong Wang

9

1 reference

10 September 2017

Jianling Zuo

10

1 reference

10 September 2017

publication date

26 September 2012

1 reference

Journal of Molecular Neuroscience

10 September 2017

published in

1 reference

10 September 2017

volume

50

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

165-171

1 reference

Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

EdU, a new thymidine analogue for labelling proliferating cells in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Regulation of gene expression by SREBP and SCAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Glioma-derived mutations in IDH: from mechanism to potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

A closer look at the cholesterol sensor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Molecular Classification of Low-Grade Diffuse Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

IDH1 mutations in grade II astrocytomas are associated with unfavorable progression‐free survival and prolonged postrecurrence survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Expression of hypoxia-inducible factor 1? in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

IDH1 mutant structures reveal a mechanism of dominant inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-012-9890-6

Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23011765

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cholesterol and cholesterol-rich membranes in prostate cancer: an update

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23011765

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23011765

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12031-012-9890-6

1 reference

10 September 2017

1 reference